The estimated Net Worth of David S Simmons is at least $42.6 Million dollars as of 14 April 2021. Mr. Simmons owns over 100,000 units of PPD Inc stock worth over $26,985,533 and over the last 12 years he sold PPD stock worth over $8,000,771. In addition, he makes $7,659,840 as Chairman of the Board and Chief Executive Officer at PPD Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Mr. Simmons PPD stock SEC Form 4 insiders trading
David has made over 7 trades of the PPD Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he sold 100,000 units of PPD stock worth $4,200,000 on 14 April 2021.
The largest trade he's ever made was selling 100,000 units of PPD Inc stock on 14 April 2021 worth over $4,200,000. On average, David trades about 14,645 units every 94 days since 2012. As of 14 April 2021 he still owns at least 570,760 units of PPD Inc stock.
You can see the complete history of Mr. Simmons stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
David Simmons biography
David S. Simmons serves as Chairman of the Board, Chief Executive Officer of the Company. Prior to joining the Company, Mr. Simmons served in various roles at Pfizer Inc. (PFE), a multinational pharmaceutical corporation, from 1996 to 2012, most recently as their president of the emerging markets and established products business units. Mr. Simmons currently serves on the board of directors for Albany Molecular Research, Inc., a contract research and manufacturing organization, and Edelman Financial Engines LLC, a financial planning and investment management firm, and serves as a member of the board of advisors for Carnegie Mellon University’s Tepper School of Business.
What is the salary of David Simmons?
As the Chairman of the Board and Chief Executive Officer of PPD Inc, the total compensation of David Simmons at PPD Inc is $7,659,840. There are no executives at PPD Inc getting paid more.
How old is David Simmons?
David Simmons is 55, he's been the Chairman of the Board and Chief Executive Officer of PPD Inc since 2012. There are 6 older and 12 younger executives at PPD Inc. The oldest executive at PPD Inc is Jeffrey Kindler, 64, who is the Independent Director.
What's David Simmons's mailing address?
David's mailing address filed with the SEC is C/O PPD, INC., 929 NORTH FRONT STREET, WILMINGTON, NC, 28401.
Insiders trading at PPD Inc
Over the last 21 years, insiders at PPD Inc have traded over $14,532,346,241 worth of PPD Inc stock and bought 130,455 units worth $3,520,800 . The most active insiders traders include Corporate Investors Viii, L..., Corporate Investors Vii, Lt..., and Group Management L.L.C.Carl.... On average, PPD Inc executives and independent directors trade stock every 53 days with the average trade being worth of $124,899,671. The most recent stock trade was executed by Corporate Investors Viii, L... on 8 December 2021, trading 132,841,266 units of PPD stock currently worth $6,309,960,135.
What does PPD Inc do?
PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Company's customers include pharmaceutical, biotechnology, medical device, academic and government organization s. With offices in 46 countries and more than 26,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help customers bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health.
What does PPD Inc's logo look like?
Complete history of Mr. Simmons stock trades at Owens & Minor, Pfizer, and PPD Inc
PPD Inc executives and stock owners
PPD Inc executives and other stock owners filed with the SEC include:
-
David Simmons,
Chairman of the Board, Chief Executive Officer -
William Sharbaugh,
Chief Operating Officer -
Christopher Scully,
Chief Financial Officer, Executive Vice President, Treasurer, Assistant Secretary -
Anshul Thakral,
Executive Vice President, Chief Commercial Officer -
B. Judd Hartman,
Executive Vice President, Chief Administrative Officer, General Counsel -
Jeffrey Kindler,
Independent Director -
Colin Hill,
Independent Director -
Maria Hilado,
Independent Director -
Tracy Krumme,
Vice President, Head of Investor Relations -
Stephen Wise,
Independent Director -
Allen Thorpe,
Independent Director -
P. Hunter Philbrick,
Independent Director -
Stephen Ensley,
Independent Director -
Joe Bress,
Independent Director -
Glen Donovan,
Chief Accounting Officer -
Roger Smith,
Senior Vice President and General Manager of AES -
Karen Kaucic,
Executive Vice President and President of Evidera, Chief Medical Officer -
David Johnston,
Executive Vice President - Global Clinical Development -
Christopher Fikry,
Executive Vice President - Global Laboratory Services -
Ronald Garrow,
Chief Human Resource Officer, Executive Vice President -
Group Inc.Carlyle Group Man...,
-
Group Management L.L.C.Carl...,
-
Jill Pellegrino,
SVP & General Manager of AES -
Peter Grunebaum,
Director -
Cecil Mark Brown,
Sr. VP & CEO -
Charlie Stephen Williamson,
Chief Financial Officer -
Kathleen Susan Pinson,
Vice President -
Randy Harp,
Chief Operating Officer -
Harland Cecil Stonecipher,
Founder, Chairman of the Board -
Martin H Belsky,
Director -
John W Hail,
Director -
Steven Riley Hague,
Director -
Paid Legal Services Inc Pre,
Director -
Judd Hartman,
See Remarks -
Thomas W Smith,
10% owner -
Corporate Investors Viii, L...,
-
Julia James,
EVP, General Counsel,Secretary